Expression of SOCSs in human prostate cancer and their association in prognosis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2013-05-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11010-013-1687-6PMID 23666742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2012

  2012cited by this paper
• SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues

  2012cited by this paper
• The SOCS box—Adapting proteins for ubiquitination and proteasomal degradation

  2012cited by this paper
• MicroRNA‐23b downregulates peroxiredoxin III in human prostate cancer

  2012cited by this paper
• Array-Comparative Genomic Hybridization Reveals Loss of SOCS6 Is Associated with Poor Prognosis in Primary Lung Squamous Cell Carcinoma

  2012cited by this paper
• Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population

  2012cited by this paper
• STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma

  2011cited by this paper
• Sox6, jack of all trades: A versatile regulatory protein in vertebrate development

  2011cited by this paper
• Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior

  2011cited by this paper
• Insulin-Like Growth Factor Signaling Regulates the Timing of Sensory Cell Differentiation in the Mouse Cochlea

  2011cited by this paper
• SOCS‐3 antagonizes pro‐apoptotic effects of TRAIL and resveratrol in prostate cancer cells

  2011cited by this paper
• SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation.

  2010cited by this paper
• Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer

  2010cited by this paper
• Tumorigenesis and Neoplastic Progression Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases

  2009cited by this paper
• Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy.

  2009cited by this paper
• Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.

  2008cited by this paper
• The many faces of the SOCS box.

  2008influential reference
• Increased SOCS6 stability with PMA requires its N-terminal region and the Erk pathway via Pkcdelta activation.

  2007cited by this paper
• Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett’s adenocarcinoma

  2007cited by this paper
• Inflammation in prostate carcinogenesis

  2007cited by this paper
• The nuclear localization of SOCS6 requires the N-terminal region and negatively regulates Stat3 protein levels.

  2007cited by this paper
• Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion.

  2007cited by this paper
• Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer.

  2006cited by this paper
• Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions.

  2006cited by this paper
• Evolution of the androgen receptor pathway during progression of prostate cancer.

  2006cited by this paper
• Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer.

  2006cited by this paper
• Tissue-specific mRNA expression profiles of human toll-like receptors and related genes.

  2005cited by this paper
• Prognostic and Predictive Relevance of DNAM-1, SOCS6 and CADH-7 Genes on Chromosome 18q in Colorectal Cancer

  2005cited by this paper
• Differential hypermethylation of SOCS genes in ovarian and breast carcinomas

  2004cited by this paper
• Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2

  2003cited by this paper
• Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.

  2001cited by this paper
• Hormone therapy for patients with prostate carcinoma

  2000cited by this paper
• Immunohistochemical localization of interleukin‐6 and its receptor in benign, premalignant and malignant prostate tissue

  2000cited by this paper
• Negative regulation of cytokine signaling pathways.

  2000cited by this paper
• Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.

  1998cited by this paper
• Cancer statistics

  1989cited by this paper

• Functional Characterization of Suppressor of Cytokine Signalling 6 and Its Interaction with Erythropoietin Receptor in Colorectal Cancer Cells

  2026cites this paper
• Unraveling the structural and functional consequences of non-synonymous single-nucleotide polymorphisms (nsSNPs) in human SOCS2: an in silico approach

  2025cites this paper
• Dysregulated expression of the suppressors of cytokine signaling (SOCS) contributes to the development of prostate cancer.

  2024cites this paper
• Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

  2024cites this paper
• The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response

  2024cites this paper
• Comprehensive analysis of suppressor of cytokine signaling 2 protein in the malignant transformation of NSCLC

  2023cites this paper
• Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes

  2023cites this paper
• Increased SOCS1 and SOCS3 expression in papillary thyroid carcinoma and its association with prognosis.

  2023cites this paper
• Molecular mechanisms of microRNA-301a during tumor progression and metastasis.

  2023cites this paper
• Extracellular vesicle‐encapsulated microRNA‐296‐3p from cancer‐associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways

  2023cites this paper
• Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles.

  2022cites this paper
• A Prognostic Model for Acute Myeloid Leukemia Based on IL-2/STAT5 Pathway-Related Genes

  2022cites this paper
• Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer

  2022cites this paper
• Inhibition of miR-1298-5p attenuates sepsis lung injury by targeting SOCS6

  2021cites this paper
• The role of N6-methyladenosine mRNA in the tumor microenvironment.

  2021cites this paper
• Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands

  2021cites this paper
• Expression Status and Prognostic Values of SOCS Family Genes in Non-small Cell Lung Cancer

  2021cites this paper
• Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer

  2021cites this paper
• Identification of Hub Genes Associated With Development and Microenvironment of Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis and Differential Gene Expression Analysis

  2020cites this paper
• Tumor-suppressor microRNA-151-5p regulates the growth, migration and invasion of human breast cancer cells by inhibiting SCOS5.

  2019cites this paper
• Transcriptomics and proteomics analyses of anti-cancer mechanisms of TR35-An active fraction from Xinjiang Bactrian camel milk in esophageal carcinoma cell.

  2019cites this paper
• MiR-492 exerts tumor-promoting function in prostate cancer through repressing SOCS2 expression.

  2019cites this paper
• Structural insights into substrate recognition by the SOCS2 E3 ubiquitin ligase

  2018cites this paper
• Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer

  2018cites this paper
• miR-196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2.

  2018cites this paper
• miR-19 promotes osteosarcoma progression by targeting SOCS6.

  2018cites this paper
• miR-24-3p stimulates migration, invasion and proliferation of prostate cancer cells by targeting suppressor of cytokine signaling 6.

  2018cites this paper
• c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks

  2017influential citation
• Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma

  2017cites this paper
• Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells.

  2017cites this paper
• MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.

  2017cites this paper
• The role of small adaptor proteins in the control of oncogenic signaling driven by tyrosine kinases in human cancer

  2016cites this paper
• Deletion of 18q is a strong and independent prognostic feature in prostate cancer

  2016cites this paper
• SOCS2: physiological and pathological functions.

  2016cites this paper
• The ubiquitin-proteasome system regulates focal adhesions at the leading edge of migrating cells

  2016cites this paper
• Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome*

  2016cites this paper
• Cell Regulation by Phosphotyrosine-Targeted Ubiquitin Ligases

  2015cites this paper
• MiR-301a Promotes Colorectal Cancer Cell Growth and Invasion by Directly Targeting SOCS6

  2015cites this paper
• Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer

  2014cites this paper
• SOCS proteins in regulation of receptor tyrosine kinase signaling

  2014influential citation
• Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover

  2014cites this paper
• miR‐17‐5p promotes proliferation by targeting SOCS6 in gastric cancer cells

  2014cites this paper
• Genome‐Wide Investigation of Regional Blood‐Based DNA Methylation Adjusted for Complete Blood Counts Implicates BNC2 in Ovarian Cancer

  2014cites this paper
• SOCS6 (suppressor of cytokine signaling 6)

  2014cites this paper
• Differential gene expression of the key signalling pathway in para‐carcinoma, carcinoma and relapse human pancreatic cancer

  2014cites this paper
• SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer

  2013cites this paper
• Post genome-wide association studies functional characterization of prostate cancer risk loci

  2013cites this paper
• SOCS2 (suppressor of cytokine signaling 2)

  2011cites this paper